US 12,252,509 B2
Neuroactive steroids and their methods of use
Maria Jesus Blanco-Pillado, Arlington, MA (US); Francesco G. Salituro, Marlborough, MA (US); and Marshall Lee Morningstar, Framingham, MA (US)
Assigned to Sage Therapeutics, Inc., Cambridge, MA (US)
Filed by SAGE THERAPEUTICS, INC., Cambridge, MA (US)
Filed on Mar. 26, 2024, as Appl. No. 18/616,903.
Application 18/616,903 is a continuation of application No. 18/334,189, filed on Jun. 13, 2023, granted, now 11,999,765.
Application 18/334,189 is a continuation of application No. 17/311,056, abandoned, previously published as PCT/US2019/064692, filed on Dec. 5, 2019.
Claims priority of provisional application 62/775,470, filed on Dec. 5, 2018.
Prior Publication US 2024/0309042 A1, Sep. 19, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. C07J 43/00 (2006.01); C07J 41/00 (2006.01)
CPC C07J 43/003 (2013.01) [C07J 41/0044 (2013.01); C07J 41/0094 (2013.01)] 19 Claims
 
1. A compound selected from
 
Example Structure
 
435
 

OG Complex Work Unit Chemistry
 
436
 

OG Complex Work Unit Chemistry
 
437
 

OG Complex Work Unit Chemistry
 
438
 

OG Complex Work Unit Chemistry
 
439
 

OG Complex Work Unit Chemistry
 
440
 

OG Complex Work Unit Chemistry
 
441
 

OG Complex Work Unit Chemistry
 
 
and
 
442
 

OG Complex Work Unit Chemistry